Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population

por Gheyath K. Nasrallah, Soha R. Dargham, Farah Shurrab, Duaa W. Al-Sadeq, Hadeel Al-Jighefee, Hiam Chemaitelly, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamda Qotba, Hamad Eid Al Romaihi, Patrick Tang, Roberto Bertollini, Mohamed H. Al-Thani, Asmaa A. Althani, Laith J. Abu-Raddad
Publicado 2021